Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins
暂无分享,去创建一个
[1] R. Jones,et al. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response. , 1982, Reviews of infectious diseases.
[2] H. Muytjens,et al. Comparative activities of 13 beta-lactam antibiotics , 1982, Antimicrobial Agents and Chemotherapy.
[3] R. Jones,et al. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing , 1980, Antimicrobial Agents and Chemotherapy.
[4] M. Nishida,et al. Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities , 1979, Antimicrobial Agents and Chemotherapy.
[5] Comparison of the In Vitro Activities of HR756 with Cephalothin, Cefoxitin, and Cefamandole , 1979, Antimicrobial Agents and Chemotherapy.
[6] H. Neu,et al. HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic Bacteria , 1979, Antimicrobial Agents and Chemotherapy.
[7] H. Neu,et al. Cefuroxime, a Beta-Lactamase-Resistant Cephalosporin with a Broad Spectrum of Gram-Positive and -Negative Activity , 1978, Antimicrobial Agents and Chemotherapy.
[8] C. O'callaghan,et al. Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro , 1976, Antimicrobial Agents and Chemotherapy.